Drug-induced phospholipidosis. I. Lipid composition and chlorphentermine content of rat lung tissue and alveolar macrophages after chronic treatment.
D000818:Animals; D001067:Appetite Depressants / Q000009:adverse effects*; D001665:Binding Sites; D002745:Chlorphentermine / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D007274:Injections, Intraperitoneal; D050356:Lipid Metabolism; D008064:Lipidoses / Q000139:chemically induced*; D008168:Lung / Q000378:metabolism*; D008264:Macrophages / Q000378:metabolism*; D008297:Male; D009929:Organ Size; D010627:Phenethylamines / Q000009:adverse effects*; D010743:Phospholipids / Q000378:metabolism*; D010955:Plasmalogens / Q000378:metabolism; D011650:Pulmonary Alveoli / Q000166:cytology / Q000378:metabolism*; D051381:Rats; D014280:Triglycerides / Q000378:metabolism
D001067:Appetite Depressants; D010627:Phenethylamines; D010743:Phospholipids; D010955:Plasmalogens; D014280:Triglycerides; D002784:Cholesterol; D002745:Chlorphentermine